{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:56Z","timestamp":1792783376888,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CARPEM"},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT209492\/Z\/17\/Z"],"award-info":[{"award-number":["WT209492\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A103 2015_A228"],"award-info":[{"award-number":["2012_A103 2015_A228"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12020-021-02645-w","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:09:25Z","timestamp":1613657365000},"page":"595-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Update on primary bilateral macronodular adrenal hyperplasia (PBMAH)"],"prefix":"10.1007","volume":"71","author":[{"given":"Lucas","family":"Bouys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-3008","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"2645_CR1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/jcem-24-10-947","volume":"24","author":"MA Kirschner","year":"1964","unstructured":"M.A. Kirschner, R.D. Powell, M.B. Lipsett, Cushing\u2019s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J. Clin. Endocrinol. Metab. 24, 947\u2013955 (1964). https:\/\/doi.org\/10.1210\/jcem-24-10-947","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR2","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","volume":"369","author":"E Louiset","year":"2013","unstructured":"E. Louiset, C. Duparc, J. Young, S. Renouf, M. Tetsi Nomigni, I. Boutelet, R. Lib\u00e9, Z. Bram, L. Groussin, P. Caron, A. Tabarin, F. Grunenberger, S. Christin-Maitre, X. Bertagna, J.-M. Kuhn, Y. Anouar, J. Bertherat, H. Lefebvre, Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N. Engl. J. Med. 369, 2115\u20132125 (2013). https:\/\/doi.org\/10.1056\/NEJMoa1215245","journal-title":"N. Engl. J. Med."},{"key":"2645_CR3","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","volume":"369","author":"G Assi\u00e9","year":"2013","unstructured":"G. Assi\u00e9, R. Lib\u00e9, S. Espiard, M. Rizk-Rabin, A. Guimier, W. Luscap, O. Barreau, L. Lef\u00e8vre, M. Sibony, L. Guignat, S. Rodriguez, K. Perlemoine, F. Ren\u00e9-Corail, F. Letourneur, B. Trabulsi, A. Poussier, N. Chabbert-Buffet, F. Borson-Chazot, L. Groussin, X. Bertagna, C.A. Stratakis, B. Ragazzon, J. Bertherat, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome. N. Engl. J. Med. 369, 2105\u20132114 (2013). https:\/\/doi.org\/10.1056\/NEJMoa1304603","journal-title":"N. Engl. J. Med."},{"key":"2645_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000134829","volume":"13","author":"CA Stratakis","year":"2008","unstructured":"C.A. Stratakis, Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome). Endocr. Dev. 13, 117\u2013132 (2008). https:\/\/doi.org\/10.1159\/000134829","journal-title":"Endocr. Dev."},{"key":"2645_CR5","doi-asserted-by":"publisher","first-page":"E926","DOI":"10.1210\/jc.2014-4204","volume":"100","author":"S Espiard","year":"2015","unstructured":"S. Espiard, L. Drougat, R. Lib\u00e9, G. Assi\u00e9, K. Perlemoine, L. Guignat, G. Barrande, F. Brucker-Davis, F. Doullay, S. Lopez, E. Sonnet, F. Torremocha, D. Pinsard, N. Chabbert-Buffet, M.-L. Raffin-Sanson, L. Groussin, F. Borson-Chazot, J. Coste, X. Bertagna, C.A. Stratakis, F. Beuschlein, B. Ragazzon, J. Bertherat, ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J. Clin. Endocrinol. Metab. 100, E926\u2013E935 (2015). https:\/\/doi.org\/10.1210\/jc.2014-4204","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12020-016-0956-z","volume":"55","author":"NM Albiger","year":"2017","unstructured":"N.M. Albiger, D. Regazzo, B. Rubin, A.M. Ferrara, S. Rizzati, E. Taschin, F. Ceccato, G. Arnaldi, F. Pecori Giraldi, A. Stigliano, L. Cerquetti, F. Grimaldi, E. De Menis, M. Boscaro, M. Iacobone, G. Occhi, C. Scaroni, A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype. Endocrine 55, 959\u2013968 (2017). https:\/\/doi.org\/10.1007\/s12020-016-0956-z","journal-title":"Endocrine"},{"key":"2645_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/EJE-11-0679","volume":"166","author":"B Gatta-Cherifi","year":"2012","unstructured":"B. Gatta-Cherifi, O. Chabre, A. Murat, P. Niccoli, C. Cardot-Bauters, V. Rohmer, J. Young, B. Delemer, H. Du Boullay, M.F. Verger, J.M. Kuhn, J.L. Sadoul, P. Ruszniewski, A. Beckers, M. Monsaingeon, E. Baudin, P. Goudet, A. Tabarin, Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs Endocrines database. Eur. J. Endocrinol. 166, 269\u2013279 (2012). https:\/\/doi.org\/10.1530\/EJE-11-0679","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR8","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","volume":"16","author":"S Gaujoux","year":"2010","unstructured":"S. Gaujoux, S. Pinson, A.-P. Gimenez-Roqueplo, L. Amar, B. Ragazzon, P. Launay, T. Meatchi, R. Lib\u00e9, X. Bertagna, A. Audebourg, J. Zucman-Rossi, F. Tissier, J. Bertherat, Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin. Cancer Res.16, 5133\u20135141 (2010). https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1497","journal-title":"Clin. Cancer Res."},{"key":"2645_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/DCR.0000000000001008","volume":"61","author":"JS Shiroky","year":"2018","unstructured":"J.S. Shiroky, J.P. Lerner-Ellis, A. Govindarajan, D.R. Urbach, K.M. Devon, Characteristics of adrenal masses in familial adenomatous polyposis. Dis. Colon Rectum 61, 679\u2013685 (2018). https:\/\/doi.org\/10.1097\/DCR.0000000000001008","journal-title":"Dis. Colon Rectum"},{"key":"2645_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","volume":"189","author":"B Shuch","year":"2013","unstructured":"B. Shuch, C.J. Ricketts, C.D. Vocke, V.A. Valera, C.C. Chen, R. Gautam, G.N. Gupta, G.S. Gomez Macias, M.J. Merino, G. Bratslavsky, W.M. Linehan, Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J. Urol. 189, 430\u2013435 (2013). https:\/\/doi.org\/10.1016\/j.juro.2012.07.139","journal-title":"J. Urol."},{"key":"2645_CR11","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2009-2321","volume":"95","author":"RJ Brown","year":"2010","unstructured":"R.J. Brown, M.H. Kelly, M.T. Collins, Cushing syndrome in the McCune-Albright syndrome. J. Clin. Endocrinol. Metab. 95, 1508\u20131515 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2321","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR12","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1210\/jc.2002-021362","volume":"88","author":"MCBV Fragoso","year":"2003","unstructured":"M.C.B.V. Fragoso, S. Domenice, A.C. Latronico, R.M. Martin, M.A.A. Pereira, M.C.N. Zerbini, A.M. Lucon, B.B. Mendonca, Cushing\u2019s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J. Clin. Endocrinol. Metab. 88, 2147\u20132151 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021362","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR13","doi-asserted-by":"publisher","first-page":"E2063","DOI":"10.1210\/jc.2012-2275","volume":"97","author":"D Vezzosi","year":"2012","unstructured":"D. Vezzosi, R. Lib\u00e9, C. Baudry, M. Rizk-Rabin, A. Horvath, I. Levy, F. Ren\u00e9-Corail, B. Ragazzon, C.A. Stratakis, G. Vandecasteele, J. Bertherat, Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors. J. Clin. Endocrinol. Metab. 97, E2063\u2013E2069 (2012). https:\/\/doi.org\/10.1210\/jc.2012-2275","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR14","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","volume":"14","author":"R Lib\u00e9","year":"2008","unstructured":"R. Lib\u00e9, A. Fratticci, J. Coste, F. Tissier, A. Horvath, B. Ragazzon, F. Rene-Corail, L. Groussin, X. Bertagna, M.L. Raffin-Sanson, C.A. Stratakis, J. Bertherat, Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin. Cancer Res. 14, 4016\u20134024 (2008). https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0106","journal-title":"Clin. Cancer Res."},{"key":"2645_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJM199210013271402","volume":"327","author":"A Lacroix","year":"1992","unstructured":"A. Lacroix, E. Bolt\u00e9, J. Tremblay, J. Dupr\u00e9, P. Poitras, H. Fournier, J. Garon, D. Garrel, F. Bayard, R. Taillefer, R.J. Flanagan, P. Hamet, Gastric inhibitory polypeptide\u2013dependent cortisol hypersecretion\u2014a new cause of Cushing\u2019s syndrome. N. Engl. J. Med. 327, 974\u2013980 (1992). https:\/\/doi.org\/10.1056\/NEJM199210013271402","journal-title":"N. Engl. J. Med"},{"key":"2645_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJM199210013271403","volume":"327","author":"Y Reznik","year":"1992","unstructured":"Y. Reznik, V. Allali-Zerah, J.A. Chayvialle, R. Leroyer, P. Leymarie, G. Travert, M.-C. Lebrethon, I. Budi, A.-M. Balliere, J. Mahoudeau, Food-dependent cushing\u2019s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N. Engl. J. Med. 327, 981\u2013986 (1992). https:\/\/doi.org\/10.1056\/NEJM199210013271403","journal-title":"N. Engl. J. Med."},{"key":"2645_CR17","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","volume":"341","author":"A Lacroix","year":"1999","unstructured":"A. Lacroix, P. Hamet, J.-M. Boutin, Leuprolide acetate therapy in luteinizing hormone\u2013dependent Cushing\u2019s syndrome. N. Engl. J. Med. 341, 1577\u20131581 (1999). https:\/\/doi.org\/10.1056\/NEJM199911183412104","journal-title":"N. Engl. J. Med."},{"key":"2645_CR18","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1210\/jcem.84.10.6068","volume":"84","author":"FP Pralong","year":"1999","unstructured":"F.P. Pralong, F. Gomez, L. Guillou, F. Mosimann, S. Franscella, R.C. Gaillard, Food-dependent Cushing\u2019s syndrome: possible involvement of leptin in cortisol hypersecretion. J. Clin. Endocrinol. Metab. 84, 3817\u20133822 (1999). https:\/\/doi.org\/10.1210\/jcem.84.10.6068","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0413","volume":"196","author":"E Louiset","year":"2008","unstructured":"E. Louiset, V. Contesse, L. Groussin, D. Cartier, C. Duparc, V. Perraudin, J. Bertherat, H. Lefebvre, Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing\u2019s syndrome: molecular, immunohistochemical and pharmacological correlates. J. Endocrinol. 196, 1\u20139 (2008). https:\/\/doi.org\/10.1677\/JOE-07-0413","journal-title":"J. Endocrinol."},{"key":"2645_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1055\/s-0034-1384522","volume":"46","author":"E Louiset","year":"2014","unstructured":"E. Louiset, C. Duparc, L. Groussin, F. Gobet, R. Desailloud, G. Barrande, Y. Reznik, J. Bertherat, G. Pr\u00e9vost, H. Lefebvre, Abnormal sensitivity to glucagon and related peptides in primary adrenal Cushing\u2019s syndrome. Horm. Metab. Res. 46, 876\u2013882 (2014). https:\/\/doi.org\/10.1055\/s-0034-1384522","journal-title":"Horm. Metab. Res."},{"key":"2645_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1210\/jc.2002-021107","volume":"88","author":"D Cartier","year":"2003","unstructured":"D. Cartier, I. Lihrmann, F. Parmentier, C. Bastard, J. Bertherat, P. Caron, J.-M. Kuhn, A. Lacroix, A. Tabarin, J. Young, H. Vaudry, H. Lefebvre, Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 88, 248\u2013254 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021107","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1530\/EJE-10-0195","volume":"163","author":"R Lib\u00e9","year":"2010","unstructured":"R. Lib\u00e9, J. Coste, L. Guignat, F. Tissier, H. Lefebvre, G. Barrande, C. Ajzenberg, I. Tauveron, E. Clauser, B. Dousset, X. Bertagna, J. Bertherat, L. Groussin, Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing\u2019s syndrome. Eur. J. Endocrinol. 163, 129\u2013138 (2010). https:\/\/doi.org\/10.1530\/EJE-10-0195","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-142","volume":"8","author":"J Hofland","year":"2013","unstructured":"J. Hofland, L.J. Hofland, P.M. van Koetsveld, J. Steenbergen, W.W. de Herder, C.H. van Eijck, R.R. de Krijger, F.H. van Nederveen, M.O. van Aken, J.W. de Groot, T.P. Links, F.H. de Jong, R.A. Feelders, ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11\u03b2-hydroxylase. Orphanet J. Rare Dis. 8, 142 (2013). https:\/\/doi.org\/10.1186\/1750-1172-8-142","journal-title":"Orphanet J. Rare Dis."},{"key":"2645_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1530\/EJE-15-0205","volume":"173","author":"R Correa","year":"2015","unstructured":"R. Correa, M. Zilbermint, A. Berthon, S. Espiard, M. Batsis, G.Z. Papadakis, P. Xekouki, M.B. Lodish, J. Bertherat, F.R. Faucz, C.A. Stratakis, The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. Eur. J. Endocrinol. 173, 435\u2013440 (2015). https:\/\/doi.org\/10.1530\/EJE-15-0205","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR25","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1073\/pnas.90.23.10914","volume":"90","author":"AG Knudson","year":"1993","unstructured":"A.G. Knudson, Antioncogenes and human cancer. Proc. Natl Acad. Sci. USA 90, 10914\u201310921 (1993). https:\/\/doi.org\/10.1073\/pnas.90.23.10914","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2645_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","volume":"460","author":"IP Cavalcante","year":"2018","unstructured":"I.P. Cavalcante, M. Nishi, M.C.N. Zerbini, M.Q. Almeida, V.B. Brondani, A. Botelho MLA de, F.Y. Tanno, V. Srougi, J.L. Chambo, B.B. Mendonca, J. Bertherat, L. CFP, M.C.B.V. Fragoso, The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH). Mol. Cell Endocrinol. 460, 36\u201346 (2018). https:\/\/doi.org\/10.1016\/j.mce.2017.06.027","journal-title":"Mol. Cell Endocrinol."},{"key":"2645_CR27","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","volume":"26","author":"A Berthon","year":"2017","unstructured":"A. Berthon, F.R. Faucz, S. Espiard, L. Drougat, J. Bertherat, C.A. Stratakis, Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function. Hum. Mol. Genet. 26, 3495\u20133507 (2017). https:\/\/doi.org\/10.1093\/hmg\/ddx235","journal-title":"Hum. Mol. Genet."},{"key":"2645_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1530\/ERC-19-0502","volume":"27","author":"IP Cavalcante","year":"2020","unstructured":"I.P. Cavalcante, A. Vaczlavik, L. Drougat, C.F.P. Lotfi, K. Perlemoine, C. Ribes, M. Rizk-Rabin, E. Clauser, M.C.B.V. Fragoso, J. Bertherat, B. Ragazzon, Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation. Endocr. Relat. Cancer 27, 221\u2013230 (2020). https:\/\/doi.org\/10.1530\/ERC-19-0502","journal-title":"Endocr. Relat. Cancer"},{"key":"2645_CR29","doi-asserted-by":"publisher","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","volume":"99","author":"L Gagliardi","year":"2014","unstructured":"L. Gagliardi, A.W. Schreiber, C.N. Hahn, J. Feng, T. Cranston, H. Boon, C. Hotu, B.E. Oftedal, R. Cutfield, D.L. Adelson, W.J. Braund, R.D. Gordon, D.A. Rees, A.B. Grossman, D.J. Torpy, H.S. Scott, ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. 99, E1784\u2013E1792 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1265","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR30","doi-asserted-by":"publisher","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","volume":"99","author":"GA Alencar","year":"2014","unstructured":"G.A. Alencar, A.M. Lerario, M.Y. Nishi, B.M. Mariani, P. de, M.Q. Almeida, J. Tremblay, P. Hamet, I. Bourdeau, M.C.N. Zerbini, M.A.A. Pereira, G.C. Gomes, M. Rocha, S. de, J.L. Chambo, A. Lacroix, B.B. Mendonca, M.C.B.V. Fragoso, ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J. Clin. Endocrinol. Metab. 99, E1501\u2013E1509 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4237","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR31","doi-asserted-by":"publisher","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","volume":"99","author":"FR Faucz","year":"2014","unstructured":"F.R. Faucz, M. Zilbermint, M.B. Lodish, E. Szarek, G. Trivellin, N. Sinaii, A. Berthon, R. Lib\u00e9, G. Assi\u00e9, S. Espiard, L. Drougat, B. Ragazzon, J. Bertherat, C.A. Stratakis, Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J. Clin. Endocrinol. Metab. 99, E1113\u2013E1119 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4280","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR32","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1210\/jc.2014-2648","volume":"100","author":"U Elbelt","year":"2015","unstructured":"U. Elbelt, A. Trovato, M. Kloth, E. Gentz, R. Finke, J. Spranger, D. Galas, S. Weber, C. Wolf, K. K\u00f6nig, W. Arlt, R. B\u00fcttner, P. May, B. Allolio, J.G. Schneider, Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. J. Clin. Endocrinol. Metab. 100, E119\u2013E128 (2015). https:\/\/doi.org\/10.1210\/jc.2014-2648","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR33","doi-asserted-by":"publisher","first-page":"8848151","DOI":"10.1155\/2020\/8848151","volume":"2020","author":"MJ Ferreira","year":"2020","unstructured":"M.J. Ferreira, J. Pedro, D. Salazar, C. Costa, J. Arag\u00e3o Rodrigues, M.M. Costa, A. Grangeia, J.L. Castedo, D. Carvalho, ARMC5 primary bilateral macronodular adrenal hyperplasia associated with a meningioma: a family report. Case Rep. Endocrinol. 2020, 8848151 (2020). https:\/\/doi.org\/10.1155\/2020\/8848151","journal-title":"Case Rep. Endocrinol."},{"key":"2645_CR34","doi-asserted-by":"publisher","first-page":"K7","DOI":"10.1530\/EJE-20-0014","volume":"183","author":"T Jojima","year":"2020","unstructured":"T. Jojima, T. Kogai, T. Iijima, K. Kato, M. Sagara, A. Kezuka, M. Kase, S. Sakurai, K. Akimoto, J. Sakumoto, T. Namatame, K. Ueki, A. Hishinuma, T. Kamai, I. Usui, Y. Aso, Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report. Eur. J. Endocrinol. 183, K7\u2013K12 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0014","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1530\/EJE-12-0777","volume":"168","author":"V Morelli","year":"2013","unstructured":"V. Morelli, S. Palmieri, A.S. Salcuni, C. Eller-Vainicher, E. Cairoli, V. Zhukouskaya, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. Eur. J. Endocrinol. 168, 235\u2013241 (2013). https:\/\/doi.org\/10.1530\/EJE-12-0777","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR36","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1\u2013G34 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR37","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/EJE-16-0461","volume":"175","author":"J Dinnes","year":"2016","unstructured":"J. Dinnes, I. Bancos, L. Ferrante di Ruffano, V. Chortis, C. Davenport, S. Bayliss, A. Sahdev, P. Guest, M. Fassnacht, J.J. Deeks, W. Arlt, Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis. Eur. J. Endocrinol. 175, R51\u2013R64 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0461","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1148\/radiology.216.3.r00au40797","volume":"216","author":"JL Doppman","year":"2000","unstructured":"J.L. Doppman, G.P. Chrousos, D.A. Papanicolaou, C.A. Stratakis, H.R. Alexander, L.K. Nieman, Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 216, 797\u2013802 (2000). https:\/\/doi.org\/10.1148\/radiology.216.3.r00au40797","journal-title":"Radiology"},{"key":"2645_CR39","first-page":"32","volume":"47","author":"U Metser","year":"2006","unstructured":"U. Metser, E. Miller, H. Lerman, G. Lievshitz, S. Avital, E. Even-Sapir, 18F-FDG PET\/CT in the evaluation of adrenal masses. J. Nucl. Med Publ. Soc. Nucl. Med. 47, 32\u201337 (2006)","journal-title":"J. Nucl. Med Publ. Soc. Nucl. Med."},{"key":"2645_CR40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2214\/AJR.08.1431","volume":"192","author":"GWL Boland","year":"2009","unstructured":"G.W.L. Boland, M.A. Blake, N.S. Holalkere, P.F. Hahn, PET\/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am. J. Roentgenol. 192, 956\u2013962 (2009). https:\/\/doi.org\/10.2214\/AJR.08.1431","journal-title":"AJR Am. J. Roentgenol."},{"key":"2645_CR41","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1210\/jc.2011-1397","volume":"96","author":"GA Alencar","year":"2011","unstructured":"G.A. Alencar, M.C.B.V. Fragoso, L.Y.I. Yamaga, A.M. Lerario, B.B. Mendonca, (18)F-FDG-PET\/CT imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased (18)F-FDG uptake. J. Clin. Endocrinol. Metab. 96, 3300\u20133301 (2011). https:\/\/doi.org\/10.1210\/jc.2011-1397","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR42","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1210\/jc.2015-2662","volume":"100","author":"E Debillon","year":"2015","unstructured":"E. Debillon, F. Velayoudom-Cephise, S. Salenave, P. Caron, P. Chaffanjon, T. Wagner, M. Massoutier, B. Lambert, M. Benoit, J. Young, A. Tabarin, O. Chabre, Unilateral adrenalectomy as a first-line treatment of cushing\u2019s syndrome in patients with primary bilateral macronodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. 100, 4417\u20134424 (2015). https:\/\/doi.org\/10.1210\/jc.2015-2662","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1210\/edrv-16-4-460","volume":"16","author":"RT Kloos","year":"1995","unstructured":"R.T. Kloos, M.D. Gross, I.R. Francis, M. Korobkin, B. Shapiro, Incidentally discovered adrenal masses. Endocr. Rev. 16, 460\u2013484 (1995). https:\/\/doi.org\/10.1210\/edrv-16-4-460","journal-title":"Endocr. Rev."},{"key":"2645_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/eje.0.1490273","volume":"149","author":"L Barzon","year":"2003","unstructured":"L. Barzon, N. Sonino, F. Fallo, G. Palu, M. Boscaro, Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol. 149, 273\u2013285 (2003). https:\/\/doi.org\/10.1530\/eje.0.1490273","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1530\/EJE-13-0848","volume":"171","author":"E Vassilatou","year":"2014","unstructured":"E. Vassilatou, A. Vryonidou, D. Ioannidis, S.A. Paschou, M. Panagou, I. Tzavara, Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. Eur. J. Endocrinol. 171, 37\u201345 (2014). https:\/\/doi.org\/10.1530\/EJE-13-0848","journal-title":"Eur. J. Endocrinol."},{"key":"2645_CR46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/archsurg.133.5.541","volume":"133","author":"JM Swain","year":"1998","unstructured":"J.M. Swain, C.S. Grant, R.T. Schlinkert, G.B. Thompson, J.A. vanHeerden, R.V. Lloyd, W.F. Young, Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Arch. Surg. 133, 541\u2013545 (1998). https:\/\/doi.org\/10.1001\/archsurg.133.5.541. discussion 545-546","journal-title":"Arch. Surg."},{"key":"2645_CR47","first-page":"215","volume":"7","author":"H Sasano","year":"1994","unstructured":"H. Sasano, T. Suzuki, H. Nagura, ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes. Mod. Pathol. J. U S Can. Acad. Pathol. Inc. 7, 215\u2013219 (1994)","journal-title":"Mod. Pathol. J. U S Can. Acad. Pathol. Inc."},{"key":"2645_CR48","doi-asserted-by":"publisher","unstructured":"M. Sheikh-Ahmad, G. Dickstein, I. Matter, C. Shechner, J. Bejar, M. Reut, G. Sroka, M. Laniado, L. Saiegh. Unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia: analysis of 71 cases. Exp Clin Endocrinol Diabetes (2019). https:\/\/doi.org\/10.1055\/a-0998-7884","DOI":"10.1055\/a-0998-7884"},{"key":"2645_CR49","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00268-007-9408-5","volume":"32","author":"M Iacobone","year":"2008","unstructured":"M. Iacobone, N. Albiger, C. Scaroni, F. Mantero, A. Fassina, G. Viel, M. Frego, G. Favia, The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J. Surg. 32, 882\u2013889 (2008). https:\/\/doi.org\/10.1007\/s00268-007-9408-5","journal-title":"World J. Surg."},{"key":"2645_CR50","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/cen.12763","volume":"82","author":"NM Albiger","year":"2015","unstructured":"N.M. Albiger, F. Ceccato, M. Zilio, M. Barbot, G. Occhi, S. Rizzati, A. Fassina, F. Mantero, M. Boscaro, M. Iacobone, C. Scaroni, An analysis of different therapeutic options in patients with Cushing\u2019s syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience. Clin. Endocrinol. (Oxf.) 82, 808\u2013815 (2015). https:\/\/doi.org\/10.1111\/cen.12763","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"2645_CR51","doi-asserted-by":"publisher","first-page":"bvaa083","DOI":"10.1210\/jendso\/bvaa083","volume":"4","author":"F Yoshiaki Tanno","year":"2020","unstructured":"F. Yoshiaki Tanno, V. Srougi, M.Q. Almeida, F. Ide Yamauchi, F. Morbeck Almeida Coelho, M.Y. Nishi, M. Claudia Nogueira Zerbini, I. Silvia Correa Soares, M. Adelaide Albergaria Pereira, H. Laiz Silva Charchar, A. Meneses Ferreira Lacombe, V. Balderrama Brondani, M. Srougi, W. Carlos Nahas, B.B. Mendonca, J. Luis Chamb\u00f4, M. Candida Barisson Villares Fragoso, A new insight into the surgical treatment of primary macronodular adrenal hyperplasia. J. Endocr. Soc. 4, bvaa083 (2020). https:\/\/doi.org\/10.1210\/jendso\/bvaa083","journal-title":"J. Endocr. Soc."},{"key":"2645_CR52","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1210\/jc.2018-02204","volume":"104","author":"A Osswald","year":"2019","unstructured":"A. Osswald, M. Quinkler, G. Di Dalmazi, T. Deutschbein, G. Rubinstein, K. Ritzel, S. Zopp, J. Bertherat, F. Beuschlein, M. Reincke, Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy. J. Clin. Endocrinol. Metab. 104, 2985\u20132993 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02204","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2645_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12020-019-02038-0","volume":"66","author":"E Papakokkinou","year":"2019","unstructured":"E. Papakokkinou, H. Jakobsson, A. Sakinis, A. Muth, B. W\u00e4ngberg, O. Ehn, G. Johannsson, O. Ragnarsson, Adrenal venous sampling in patients with ACTH-independent hypercortisolism. Endocrine 66, 338\u2013348 (2019). https:\/\/doi.org\/10.1007\/s12020-019-02038-0","journal-title":"Endocrine"},{"key":"2645_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00268-018-4788-2","volume":"43","author":"R Acharya","year":"2019","unstructured":"R. Acharya, M. Dhir, R. Bandi, L. Yip, S. Challinor, Outcomes of adrenal venous sampling in patients with bilateral adrenal masses and ACTH-independent Cushing\u2019s syndrome. World J. Surg. 43, 527\u2013533 (2019). https:\/\/doi.org\/10.1007\/s00268-018-4788-2","journal-title":"World J. Surg."},{"key":"2645_CR55","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1210\/jc.2017-00823","volume":"102","author":"M Debono","year":"2017","unstructured":"M. Debono, R.F. Harrison, R. Chadarevian, C. Gueroult, J.-L. Abitbol, J. Newell-Price, Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 102, 3461\u20133469 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00823","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-021-02645-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T06:46:24Z","timestamp":1617259584000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-021-02645-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2645"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02645-w","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"1 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M.R. has received speakers and consultancy fees from Recordati and Novartis. J.B. has received speakers and consultancy fees from HRA pharma, Novartis, Corcept, and Recordati. I.C. has received speaker and consultancy fees from HRA pharma and Corcept. The other authors have no conflict of interest concerning this review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}